Goldman Sachs’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.1M | Buy |
|
|||||
|
2025
Q2 | $20.1M | Sell |
|
|||||
|
2025
Q1 | $21.5M | Sell |
|
|||||
|
2024
Q4 | $23M | Sell |
|
|||||
|
2024
Q3 | $24.9M | Sell |
|
|||||
|
2024
Q2 | $26M | Buy |
|
|||||
|
2024
Q1 | $17.6M | Buy |
|
|||||
|
2023
Q4 | $13.5M | Buy |
|
|||||
|
2023
Q3 | $7.61M | Sell |
|
|||||
|
2023
Q2 | $7.11M | Sell |
|
|||||
|
2023
Q1 | $9.42M | Sell |
|
|||||
|
2022
Q4 | $8.61M | Buy |
|
|||||
|
2022
Q3 | $4.96M | Buy |
|
|||||
|
2022
Q2 | $2.37M | Buy |
|
|||||
|
2022
Q1 | $633K | Sell |
|
|||||
|
2021
Q4 | $658K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $442K | Sell |
|
|||||
|
2020
Q2 | $602K | Sell |
|
|||||
|
2020
Q1 | $534K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $111K | Buy |
|